Not Tagged
Not Tagged
['brca']
 brcamut pts derive greater rpfs benefit (hr 0.20) than non-brca-hrrmut (hr 0.68). in populations with different prognosis and post-progression tx options (parpi monother only in brcamut), will it make sense to group them together in future trials/analyses?
Medical Oncologist at the Hospital Provincial Castellón